Loading…

UHPLC-MS/MS method for the determination of the cyclic depsipeptide mycotoxins beauvericin and enniatins in in vitro transdermal experiments

•We developed a high-throughput bioanalytical UHPLC-MS/MS method for BEA and ENNs.•Significant adsorption to glass occurs, depending on solvent composition.•BEA and ENNs are chemically stable under in vitro transdermal test conditions. Currently, dermal exposure data of cyclic depsipeptide mycotoxin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 2014-11, Vol.100, p.50-57
Main Authors: Taevernier, Lien, Veryser, Lieselotte, Vandercruyssen, Kirsten, D’Hondt, Matthias, Vansteelandt, Stijn, De Saeger, Sarah, De Spiegeleer, Bart
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-3b0d9c6455bc555bf1ff4242e6eb48075fbb86ba0b1111d4e34e087e3442b4e3
cites cdi_FETCH-LOGICAL-c356t-3b0d9c6455bc555bf1ff4242e6eb48075fbb86ba0b1111d4e34e087e3442b4e3
container_end_page 57
container_issue
container_start_page 50
container_title Journal of pharmaceutical and biomedical analysis
container_volume 100
creator Taevernier, Lien
Veryser, Lieselotte
Vandercruyssen, Kirsten
D’Hondt, Matthias
Vansteelandt, Stijn
De Saeger, Sarah
De Spiegeleer, Bart
description •We developed a high-throughput bioanalytical UHPLC-MS/MS method for BEA and ENNs.•Significant adsorption to glass occurs, depending on solvent composition.•BEA and ENNs are chemically stable under in vitro transdermal test conditions. Currently, dermal exposure data of cyclic depsipeptide mycotoxins beauvericin and enniatins are completely absent with a lack of local skin and systemic kinetics, despite their widespread skin contact and intrinsic hazard. Therefore a sensitive and specific bioanalytical high-throughput UHPLC-MS/MS method was developed for the quantitative and simultaneous determination of cyclic depsipeptide mycotoxins beauvericin and enniatins (A, A1, B, B1, D, E, C/F) in human skin Franz diffusion cell samples. The limits of detection ranged between 10 and 17pg/ml, while the total run time was only 4.5min. There was no significant effect of endogenous skin compounds on the mycotoxin MS signal observed, and the accuracy (0.68–24.68% bias) and precision (0.57–10.70% RSD) were considered acceptable for our purposes. Moreover, it was demonstrated that these cyclic depsipeptides are stable for at least 7 days when formulated in different organic or aqueous mixtures. Finally, adsorption to glass did occur: at least 50% ethanol or acetonitrile is required to prevent significant adsorption effects, which could be as high as 45%.
doi_str_mv 10.1016/j.jpba.2014.07.021
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566825770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708514003549</els_id><sourcerecordid>1566825770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-3b0d9c6455bc555bf1ff4242e6eb48075fbb86ba0b1111d4e34e087e3442b4e3</originalsourceid><addsrcrecordid>eNp9UV1rFDEUDaLYtfoHfJA8-jLTJJNMpuCLLNUWtii0gm8hH3dolplkTLJL9z_4o826rY-GSy733nMONzkIvaekpYT2F9t2uxjdMkJ5S2RLGH2BVnSQXcN6_vMlWhHZ0UaSQZyhNzlvCSGCXvLX6IwJyoZBihX6_eP6-2bd3N5d3N7hGcpDdHiMCZcHwA4KpNkHXXwMOI5_m_ZgJ2_rbMl-gaV4B3g-2Fjiow8ZG9C7PSRvfcA6OAwh-Mqvk9qosfclRVySDtlVcT1heFwqfoZQ8lv0atRThndP-Rzdf7m6X183m29fb9afN43tRF-azhB3aXsuhLGiXiMdR844gx4MH4gUozFDbzQxtB7HoeNABlkTZ6ZW5-jjSXZJ8dcOclGzzxamSQeIu6yo6PuBCSlJhbIT1KaYc4JRLXVXnQ6KEnU0QW3V0QR1NEERqaoJlfThSX9nZnD_KM-_XgGfTgCoj9x7SCpbD8GC8wlsUS76_-n_ARnJmwk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566825770</pqid></control><display><type>article</type><title>UHPLC-MS/MS method for the determination of the cyclic depsipeptide mycotoxins beauvericin and enniatins in in vitro transdermal experiments</title><source>Elsevier</source><creator>Taevernier, Lien ; Veryser, Lieselotte ; Vandercruyssen, Kirsten ; D’Hondt, Matthias ; Vansteelandt, Stijn ; De Saeger, Sarah ; De Spiegeleer, Bart</creator><creatorcontrib>Taevernier, Lien ; Veryser, Lieselotte ; Vandercruyssen, Kirsten ; D’Hondt, Matthias ; Vansteelandt, Stijn ; De Saeger, Sarah ; De Spiegeleer, Bart</creatorcontrib><description>•We developed a high-throughput bioanalytical UHPLC-MS/MS method for BEA and ENNs.•Significant adsorption to glass occurs, depending on solvent composition.•BEA and ENNs are chemically stable under in vitro transdermal test conditions. Currently, dermal exposure data of cyclic depsipeptide mycotoxins beauvericin and enniatins are completely absent with a lack of local skin and systemic kinetics, despite their widespread skin contact and intrinsic hazard. Therefore a sensitive and specific bioanalytical high-throughput UHPLC-MS/MS method was developed for the quantitative and simultaneous determination of cyclic depsipeptide mycotoxins beauvericin and enniatins (A, A1, B, B1, D, E, C/F) in human skin Franz diffusion cell samples. The limits of detection ranged between 10 and 17pg/ml, while the total run time was only 4.5min. There was no significant effect of endogenous skin compounds on the mycotoxin MS signal observed, and the accuracy (0.68–24.68% bias) and precision (0.57–10.70% RSD) were considered acceptable for our purposes. Moreover, it was demonstrated that these cyclic depsipeptides are stable for at least 7 days when formulated in different organic or aqueous mixtures. Finally, adsorption to glass did occur: at least 50% ethanol or acetonitrile is required to prevent significant adsorption effects, which could be as high as 45%.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2014.07.021</identifier><identifier>PMID: 25128875</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Adsorption ; Beauvericin ; Bioanalytical UHPLC-MS/MS method ; Calibration ; Chromatography, High Pressure Liquid - methods ; Chromatography, High Pressure Liquid - standards ; Depsipeptides - chemistry ; Depsipeptides - metabolism ; Diffusion Chambers, Culture ; Drug Stability ; Enniatins ; Glass - chemistry ; High-Throughput Screening Assays - methods ; High-Throughput Screening Assays - standards ; Humans ; Kinetics ; Limit of Detection ; Linear Models ; Permeability ; Reference Standards ; Skin - metabolism ; Skin Absorption ; Spectrometry, Mass, Electrospray Ionization - standards ; Tandem Mass Spectrometry - standards ; Transdermal Franz diffusion cell</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2014-11, Vol.100, p.50-57</ispartof><rights>2014 Elsevier B.V.</rights><rights>Copyright © 2014 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-3b0d9c6455bc555bf1ff4242e6eb48075fbb86ba0b1111d4e34e087e3442b4e3</citedby><cites>FETCH-LOGICAL-c356t-3b0d9c6455bc555bf1ff4242e6eb48075fbb86ba0b1111d4e34e087e3442b4e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25128875$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taevernier, Lien</creatorcontrib><creatorcontrib>Veryser, Lieselotte</creatorcontrib><creatorcontrib>Vandercruyssen, Kirsten</creatorcontrib><creatorcontrib>D’Hondt, Matthias</creatorcontrib><creatorcontrib>Vansteelandt, Stijn</creatorcontrib><creatorcontrib>De Saeger, Sarah</creatorcontrib><creatorcontrib>De Spiegeleer, Bart</creatorcontrib><title>UHPLC-MS/MS method for the determination of the cyclic depsipeptide mycotoxins beauvericin and enniatins in in vitro transdermal experiments</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>•We developed a high-throughput bioanalytical UHPLC-MS/MS method for BEA and ENNs.•Significant adsorption to glass occurs, depending on solvent composition.•BEA and ENNs are chemically stable under in vitro transdermal test conditions. Currently, dermal exposure data of cyclic depsipeptide mycotoxins beauvericin and enniatins are completely absent with a lack of local skin and systemic kinetics, despite their widespread skin contact and intrinsic hazard. Therefore a sensitive and specific bioanalytical high-throughput UHPLC-MS/MS method was developed for the quantitative and simultaneous determination of cyclic depsipeptide mycotoxins beauvericin and enniatins (A, A1, B, B1, D, E, C/F) in human skin Franz diffusion cell samples. The limits of detection ranged between 10 and 17pg/ml, while the total run time was only 4.5min. There was no significant effect of endogenous skin compounds on the mycotoxin MS signal observed, and the accuracy (0.68–24.68% bias) and precision (0.57–10.70% RSD) were considered acceptable for our purposes. Moreover, it was demonstrated that these cyclic depsipeptides are stable for at least 7 days when formulated in different organic or aqueous mixtures. Finally, adsorption to glass did occur: at least 50% ethanol or acetonitrile is required to prevent significant adsorption effects, which could be as high as 45%.</description><subject>Adsorption</subject><subject>Beauvericin</subject><subject>Bioanalytical UHPLC-MS/MS method</subject><subject>Calibration</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Chromatography, High Pressure Liquid - standards</subject><subject>Depsipeptides - chemistry</subject><subject>Depsipeptides - metabolism</subject><subject>Diffusion Chambers, Culture</subject><subject>Drug Stability</subject><subject>Enniatins</subject><subject>Glass - chemistry</subject><subject>High-Throughput Screening Assays - methods</subject><subject>High-Throughput Screening Assays - standards</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Limit of Detection</subject><subject>Linear Models</subject><subject>Permeability</subject><subject>Reference Standards</subject><subject>Skin - metabolism</subject><subject>Skin Absorption</subject><subject>Spectrometry, Mass, Electrospray Ionization - standards</subject><subject>Tandem Mass Spectrometry - standards</subject><subject>Transdermal Franz diffusion cell</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9UV1rFDEUDaLYtfoHfJA8-jLTJJNMpuCLLNUWtii0gm8hH3dolplkTLJL9z_4o826rY-GSy733nMONzkIvaekpYT2F9t2uxjdMkJ5S2RLGH2BVnSQXcN6_vMlWhHZ0UaSQZyhNzlvCSGCXvLX6IwJyoZBihX6_eP6-2bd3N5d3N7hGcpDdHiMCZcHwA4KpNkHXXwMOI5_m_ZgJ2_rbMl-gaV4B3g-2Fjiow8ZG9C7PSRvfcA6OAwh-Mqvk9qosfclRVySDtlVcT1heFwqfoZQ8lv0atRThndP-Rzdf7m6X183m29fb9afN43tRF-azhB3aXsuhLGiXiMdR844gx4MH4gUozFDbzQxtB7HoeNABlkTZ6ZW5-jjSXZJ8dcOclGzzxamSQeIu6yo6PuBCSlJhbIT1KaYc4JRLXVXnQ6KEnU0QW3V0QR1NEERqaoJlfThSX9nZnD_KM-_XgGfTgCoj9x7SCpbD8GC8wlsUS76_-n_ARnJmwk</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Taevernier, Lien</creator><creator>Veryser, Lieselotte</creator><creator>Vandercruyssen, Kirsten</creator><creator>D’Hondt, Matthias</creator><creator>Vansteelandt, Stijn</creator><creator>De Saeger, Sarah</creator><creator>De Spiegeleer, Bart</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141101</creationdate><title>UHPLC-MS/MS method for the determination of the cyclic depsipeptide mycotoxins beauvericin and enniatins in in vitro transdermal experiments</title><author>Taevernier, Lien ; Veryser, Lieselotte ; Vandercruyssen, Kirsten ; D’Hondt, Matthias ; Vansteelandt, Stijn ; De Saeger, Sarah ; De Spiegeleer, Bart</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-3b0d9c6455bc555bf1ff4242e6eb48075fbb86ba0b1111d4e34e087e3442b4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adsorption</topic><topic>Beauvericin</topic><topic>Bioanalytical UHPLC-MS/MS method</topic><topic>Calibration</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Chromatography, High Pressure Liquid - standards</topic><topic>Depsipeptides - chemistry</topic><topic>Depsipeptides - metabolism</topic><topic>Diffusion Chambers, Culture</topic><topic>Drug Stability</topic><topic>Enniatins</topic><topic>Glass - chemistry</topic><topic>High-Throughput Screening Assays - methods</topic><topic>High-Throughput Screening Assays - standards</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Limit of Detection</topic><topic>Linear Models</topic><topic>Permeability</topic><topic>Reference Standards</topic><topic>Skin - metabolism</topic><topic>Skin Absorption</topic><topic>Spectrometry, Mass, Electrospray Ionization - standards</topic><topic>Tandem Mass Spectrometry - standards</topic><topic>Transdermal Franz diffusion cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taevernier, Lien</creatorcontrib><creatorcontrib>Veryser, Lieselotte</creatorcontrib><creatorcontrib>Vandercruyssen, Kirsten</creatorcontrib><creatorcontrib>D’Hondt, Matthias</creatorcontrib><creatorcontrib>Vansteelandt, Stijn</creatorcontrib><creatorcontrib>De Saeger, Sarah</creatorcontrib><creatorcontrib>De Spiegeleer, Bart</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taevernier, Lien</au><au>Veryser, Lieselotte</au><au>Vandercruyssen, Kirsten</au><au>D’Hondt, Matthias</au><au>Vansteelandt, Stijn</au><au>De Saeger, Sarah</au><au>De Spiegeleer, Bart</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>UHPLC-MS/MS method for the determination of the cyclic depsipeptide mycotoxins beauvericin and enniatins in in vitro transdermal experiments</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>100</volume><spage>50</spage><epage>57</epage><pages>50-57</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><abstract>•We developed a high-throughput bioanalytical UHPLC-MS/MS method for BEA and ENNs.•Significant adsorption to glass occurs, depending on solvent composition.•BEA and ENNs are chemically stable under in vitro transdermal test conditions. Currently, dermal exposure data of cyclic depsipeptide mycotoxins beauvericin and enniatins are completely absent with a lack of local skin and systemic kinetics, despite their widespread skin contact and intrinsic hazard. Therefore a sensitive and specific bioanalytical high-throughput UHPLC-MS/MS method was developed for the quantitative and simultaneous determination of cyclic depsipeptide mycotoxins beauvericin and enniatins (A, A1, B, B1, D, E, C/F) in human skin Franz diffusion cell samples. The limits of detection ranged between 10 and 17pg/ml, while the total run time was only 4.5min. There was no significant effect of endogenous skin compounds on the mycotoxin MS signal observed, and the accuracy (0.68–24.68% bias) and precision (0.57–10.70% RSD) were considered acceptable for our purposes. Moreover, it was demonstrated that these cyclic depsipeptides are stable for at least 7 days when formulated in different organic or aqueous mixtures. Finally, adsorption to glass did occur: at least 50% ethanol or acetonitrile is required to prevent significant adsorption effects, which could be as high as 45%.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>25128875</pmid><doi>10.1016/j.jpba.2014.07.021</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2014-11, Vol.100, p.50-57
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_1566825770
source Elsevier
subjects Adsorption
Beauvericin
Bioanalytical UHPLC-MS/MS method
Calibration
Chromatography, High Pressure Liquid - methods
Chromatography, High Pressure Liquid - standards
Depsipeptides - chemistry
Depsipeptides - metabolism
Diffusion Chambers, Culture
Drug Stability
Enniatins
Glass - chemistry
High-Throughput Screening Assays - methods
High-Throughput Screening Assays - standards
Humans
Kinetics
Limit of Detection
Linear Models
Permeability
Reference Standards
Skin - metabolism
Skin Absorption
Spectrometry, Mass, Electrospray Ionization - standards
Tandem Mass Spectrometry - standards
Transdermal Franz diffusion cell
title UHPLC-MS/MS method for the determination of the cyclic depsipeptide mycotoxins beauvericin and enniatins in in vitro transdermal experiments
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A06%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=UHPLC-MS/MS%20method%20for%20the%20determination%20of%20the%20cyclic%20depsipeptide%20mycotoxins%20beauvericin%20and%20enniatins%20in%20in%20vitro%20transdermal%20experiments&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Taevernier,%20Lien&rft.date=2014-11-01&rft.volume=100&rft.spage=50&rft.epage=57&rft.pages=50-57&rft.issn=0731-7085&rft.eissn=1873-264X&rft_id=info:doi/10.1016/j.jpba.2014.07.021&rft_dat=%3Cproquest_cross%3E1566825770%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-3b0d9c6455bc555bf1ff4242e6eb48075fbb86ba0b1111d4e34e087e3442b4e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1566825770&rft_id=info:pmid/25128875&rfr_iscdi=true